Serum samples for anti-panitumumab antibody testing were collected from mCRC patients enrolled in 4 panitumumab clinical trials (20050184, 20060277, 20050181, and 20050203). Patients in these ...

“Colorectal-cancer researchers have waited nearly a decade to obtain definitive evidence on the effectiveness of panitumumab versus bevacizumab,” says Yoshino. “The results have led to a ...

BMC Clin Pharmacol. 2011;11(17):1-10. The fully human nature of panitumumab was expected to decrease the rate of immunogenicity compared with therapeutic antibodies containing nonhuman coding ...